Technologies · 05/11/20261 min de lecture
Medical Devices; Neurological Devices; Classification of the Prognostic Assessment Software of Mild Cognitive Impairment
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is classifying the prognostic assessment software of mild cognitive impairment into class II (special controls).